Hypertension
Conditions
Interventions
Large Language Model Intervention Group:In addition to conventional treatment (standard drug therapy protocols, standardized lifestyle guidance delivered orally or in print), implement comprehensive r
Conventional Treatment Group:In addition to conventional treatment (standard drug therapy regimen, standardized lifestyle guidance provided verbally or in print), participants receive the same persona
Sponsors
Southern Medical University Zhujiang Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Diagnosed with hypertension (2) Voluntarily participate in the trial and sign the informed consent form; (3) Age >= 18 years and <= 80 years; (4) Passed the physical activity level questionnaire screening or was approved by the physician before participation; (5) Can communicate normally and cooperate with the questionnaire survey; (6) Has an intelligent device (such as a mobile phone, tablet), and can access WeChat and the Internet through the intelligent device.
Exclusion criteria
Exclusion criteria: (1) Patients with secondary hypertension; (2) Patients with severe hypertension or whose blood pressure has not been effectively controlled (i.e., resting systolic blood pressure = 180 mmHg and/or diastolic blood pressure = 110 mmHg); (3) Patients with pulmonary hypertension, severe hypertension, hypertensive crisis, unstable stage III hypertension, hypertensive encephalopathy or rapidly progressive hypertension, or those with other serious complications such as severe arrhythmia, tachycardia, heart failure, unstable angina pectoris, or obvious adverse reactions to antihypertensive drugs that have not been controlled; (4) Patients with malignant tumors or those with hypertension combined with left ventricular ejection fraction less than 55%, combined with aortic valve, mitral valve, tricuspid valve, or pulmonary artery stenosis, combined with severe insufficiency of mitral valve, tricuspid valve, or pulmonary valve; (5) Patients with musculoskeletal organ damage, who have undergone bone and joint surgery within < 1 year, such as hip joint, knee joint replacement surgery, spinal surgery, etc. (6) Participants in other studies related to the promotion of healthy lifestyle (such as physical exercise); (7) Patients considered unsuitable for participating in clinical trials by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life Assessment (SF-12) scale score; | — |
Secondary
| Measure | Time frame |
|---|---|
| 6-minute walk test;30-Second Sit-to-Stand Test;Activity Balance Confidence Scale (ABC);Depression Self-Rating Scale (PHQ-9);Generalized Anxiety Disorder Scale (GAD-7);Hypertension Knowledge Level Scale (HK-LS);International Physical Activity Questionnaire Short Form (IPAQ-S);Morisky Chinese Revised Version Medication Adherence Scale (MMAS-8);Level of brain function activation; | — |
Countries
China
Contacts
Public ContactHuang Guozhi;Zeng Qing
Southern Medical University Zhujiang Hospital
Outcome results
None listed